Enoxaparin is a low molecular weight heparin manufactured by Sanofi-Aventis. It is marketed as Lovenox or Clexane.
Enoxaparin is used to prevent and treat deep vein thrombosis or pulmonary embolism, and is given as a subcutaneous injection (by a health care provider or the patient). Its use is evolving in acute coronary syndromes.
In the UK, enoxaparin is approved for five indications:
More on [ Enoxaparin ]

Lovenox - Enoxaparin sodium. Features information for patients and physicians including tips and instructions, interactions, prescribing information, description of potential uses, and dosing details.
Meta Description: [ Learn about an anticoagulant treatment used to fight against deep vein thrombosis (DVT), also called leg blood clots. Find out if you are at risk of developing leg blood clots, learn more about DVT and possible complications, and much more. ]